Global TCR-based Therapy Market(2022–2035)
Growing burden and unaddressed complex treatment needs of cancer patients have paved the way for more effective, safe and versatile alternatives, such as TCR therapies. Driven by Kimmtrak® approval, promising development pipeline and encouraging clinical trial results, the TCR-based therapy market is anticipated to witness significant growth in the mid to long-term. key drivers and trends A detailed assessment of the current market landscape of TCR-based therapies. An analysis of the popular target antigens related to hematological malignancies and solid tumors. A detailed analysis of completed, ongoing and planned clinical studies related to TCR-based therapies. An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TCR-based therapies. Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above). An analysis of various types of ...